Magnetecs
Stage
Unattributed - II | AliveTotal Raised
$30.2MLast Raised
$4.37M | 8 yrs agoAbout Magnetecs
Magnetecs is a company that focuses on the design and manufacture of medical technology, specifically within the healthcare industry. The company's main product is a robotic Catheter Guidance Control and Imaging (CGCI) system, which is used for minimally invasive medical procedures. This system uses an electromagnetic array to guide a magnetically-tipped catheter, allowing physicians to control surgical tools with precision and consistency, enhancing safety and dexterity. It is based in Inglewood, California.
Loading...
Loading...
Expert Collections containing Magnetecs
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Magnetecs is included in 2 Expert Collections, including Robotics.
Robotics
1,974 items
This collection includes startups developing autonomous ground robots, unmanned aerial vehicles, robotic arms, and underwater drones, among other robotic systems. This collection also includes companies developing operating systems and vision modules for robots.
Digital Health
10,595 items
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.
Magnetecs Patents
Magnetecs has filed 12 patents.
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
4/19/2012 | 5/23/2017 | Medical equipment, Catheters, Personal rapid transit, Medical equipment manufacturers, Protein domains | Grant |
Application Date | 4/19/2012 |
|---|---|
Grant Date | 5/23/2017 |
Title | |
Related Topics | Medical equipment, Catheters, Personal rapid transit, Medical equipment manufacturers, Protein domains |
Status | Grant |
Latest Magnetecs News
Dec 19, 2011
Magnetecs, an Inglewood, California firm, received the European CE Marking for its Robotic Catheter Guidance Control and Imaging (CGCI) System. The technology involves eight remotely controlled electromagnets that guide the movement of a magnetically-tipped EP catheter, providing precise movement with great dexterity. The display intelligently provides validation of anatomy, EP, and precise visualization of the intended work area as well as real-time display of tool location. Automated mapping of the cardiac chamber of interest removes the repetitive task of manual mapping, thereby shortening the duration of the procedure and increasing the accuracy of the generated map. Since all the imaging, tool location and control operates in the digital realm, the entire procedure is stored and available for review and playback.According to Josh Shachar, CEO of Magnetecs, the European regulatory decision will allow the company to apply its technology “for electrophysiology and interventional cardiology as well as additional fields of use.”Read More
Magnetecs Frequently Asked Questions (FAQ)
Where is Magnetecs's headquarters?
Magnetecs's headquarters is located at 10524 S LA Cienega Blvd., Inglewood.
What is Magnetecs's latest funding round?
Magnetecs's latest funding round is Unattributed - II.
How much did Magnetecs raise?
Magnetecs raised a total of $30.2M.
Who are the investors of Magnetecs?
Investors of Magnetecs include Atid Capital Partners and St. Jude Medical.
Who are Magnetecs's competitors?
Competitors of Magnetecs include BioProtect, GENICON, Spine View, PEAK Surgical, Sierra Surgical Technologies and 7 more.
Loading...
Compare Magnetecs to Competitors
Axis Surgical Technologies, Inc. aims to develop, manufacture, and market devices that improve quality and efficiency in spinal surgery, especially for minimally invasive surgical techniques. Based in Mountain View, California, Axis offers an integration of visualization and articulation capabilities and provides spinal surgery equipment. Axis' FDA Grant In March 2010, Axis announced that it received 510(k) clearance from the Food and Drug Administration to market its C-MOR„ Visualization Device to use in diagnostic and operative arthroscopic and endoscopic procedures. This portable tool provides visualization and illumination of an interior cavity through either a natural or surgical opening. The ergonomic lightweight device also offers practitioners the convenience of endoscopic visualization and efficient one-handed operating ability; this device can be employed in hospital outpatient departments, ambulatory surgery centers, and office surgery suites.
BioProtect develops radiation protection technology in the healthcare industry. The company offers biodegradable balloon spacers that create a safe distance between the prostate and rectum during radiation therapy, reducing radiation exposure to healthy tissue. It serves the oncology sector, with a particular emphasis on prostate cancer treatment. The company was founded in 2004 and is based in Tzur Yigal, Israel.
NeoChord is a medical technology company engaged in the advancement of beating heart mitral valve repair in patients suffering from mitral valve regurgitation. The company's flagship product, the NeoChord Artificial Chordae Delivery System, is a beating heart procedure, echo-guided treatment for patients with mitral valve regurgitation, and is proven to resolve and restore normal mitral valve function. It was formerly known as mValve. The company was founded in 2007 and is based in St. Louis Park, Minnesota.
Advanced Surgical Concepts develops surgical instruments for use in endoscopy and in minimally invasive surgery
Mpathy Medical has developed a range of less invasive surgical solutions to restore pelvic health to women. The company's responsive team aims to provide a relationship with the individuals who really matter, women and their surgeons.
SuturTek is a healthcare company with a patented platform technology for a portfolio of products that aim to precisely replicate traditional hand suturing techniques providing faster, easier, safer suturing in both currently sutured procedures as well as additional open and minimally invasive procedures. It's first product was for fascia closure and was followed by a sternum closing device.
Loading...